Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Recursion Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
RXRX
Nasdaq
8731
https://www.recursion.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals (RXRX) Stock Dips While Market Gains: Key Facts
- Oct 2nd, 2024 9:50 pm
Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma
- Oct 2nd, 2024 12:00 pm
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
- Sep 29th, 2024 9:44 am
Is Recursion Pharmaceuticals Stock a Buy?
- Sep 20th, 2024 12:30 pm
Recursion Pharmaceuticals, Inc. (RXRX): A Very Important AI Stock According to BlackRock
- Sep 12th, 2024 2:53 pm
Recursion Pharmaceuticals, Inc. (RXRX): Among the Worst ARK Stocks According to Short Sellers
- Sep 8th, 2024 8:51 pm
Recursion Stock Down Despite Meeting Goal in Brain Disease Study
- Sep 4th, 2024 3:14 pm
Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability
- Sep 3rd, 2024 12:00 pm
AI specialist Recursion says lead drug is safe, but efficacy less clear
- Sep 3rd, 2024 11:11 am
Is Recursion Pharmaceuticals a Warren Buffett Stock?
- Aug 30th, 2024 8:10 am
Recursion Pharmaceuticals Inc. (RXRX): Among The Best Medical AI Companies
- Aug 28th, 2024 11:04 pm
The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why.
- Aug 18th, 2024 4:34 pm
These Stocks in Nvidia's Portfolio Took a Hit in the Second Quarter
- Aug 16th, 2024 10:36 pm
Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks
- Aug 13th, 2024 11:05 am
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
- Aug 12th, 2024 1:15 pm
Is Recursion Pharmaceuticals a Buy Ahead of Its Merger With Exscientia?
- Aug 11th, 2024 8:59 am
AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals
- Aug 8th, 2024 9:37 pm
Recursion Pharmaceuticals (RXRX) Reports Q2 Loss, Tops Revenue Estimates
- Aug 8th, 2024 12:45 pm
Recursion Pharmaceuticals: Q2 Earnings Snapshot
- Aug 8th, 2024 11:45 am
Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities
- Aug 8th, 2024 11:39 am
Scroll